Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Post-PCI corrected TIMI Frame Count predicts left ventricular global longitudinal strain at 90 days post-STEMI in thrombolysis-treated patients: A pre-specified analysis of the MIRTOS study.
Anastasiou I, Patrianakos A, Vernardos M, Foukarakis E, Pitarokoilis M, Petousis S, Zacharis E, Marketou M, Skalidis E, Kochiadakis G, Parthenakis F, Vardas P, Hamilos M. Anastasiou I, et al. Am Heart J Plus. 2022 Nov 3;23:100222. doi: 10.1016/j.ahjo.2022.100222. eCollection 2022 Nov. Am Heart J Plus. 2022. PMID: 38560654 Free PMC article.
Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement.
Schlaich MP, Tsioufis K, Taddei S, Ferri C, Cooper M, Sindone A, Borghi C, Parissis J, Marketou M, Vintila AM, Farcas A, Kiuchi MG, Chandrappa S. Schlaich MP, et al. J Hypertens. 2024 Dec 1;42(12):2025-2040. doi: 10.1097/HJH.0000000000003769. Epub 2024 Sep 23. J Hypertens. 2024. PMID: 38747424 Free PMC article. Review.
SPECT/CT SUV-based metrics: A promising diagnostic tool in classifying patients with suspected transthyretin cardiac amyloidosis among the different Perugini grades?
Koukouraki S, Kapsoritakis N, Bourogianni O, Stathaki M, Zaganas I, Patrianakos A, Plevritaki A, Korela D, Marketou M, Foukarakis E. Koukouraki S, et al. Hell J Nucl Med. 2023 Sep-Dec;26(3):172-180. doi: 10.1967/s002449912601. Epub 2023 Dec 14. Hell J Nucl Med. 2023. PMID: 38085832 Free article.
124 results